South Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shot


  • World
  • Wednesday, 05 May 2021

FILE PHOTO: A health worker gets a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a COVID-19 vaccination center in Seoul, South Korea, March 10, 2021. REUTERS/Kim Hong-Ji

SEOUL (Reuters) - One dose of COVID-19 vaccines from AstraZeneca Plc and Pfizer was 86.6% effective in preventing infections among people aged 60 and older, real world data released by South Korea showed on Wednesday.

Data by the Korea Disease Control and Prevention Agency (KDCA) showed the Pfizer vaccine, jointly developed by BioNTech, was 89.7% effective in preventing infection at least two weeks after a first dose was given, while the AstraZeneca shot was 86.0% effective.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

1st LD Writethru: U.S. military aircraft crashes into San Diego Bay
Russia, Sudan agree on Red Sea naval base, Sudanese foreign minister says
U.S. military aircraft crashes into San Diego Bay
Belarus releases three detainees, including an American, White House says
ACLU lawsuit seeks access to migrants sent to Guantanamo Bay
Crude futures settle lower
Zelenskiy, Trump discuss 'opportunities to achieve peace' by phone
Canada, EU seek stronger trade partnership amid U.S. tariffs
U.S. dollar ticks down
Exclusive-Russian-linked bots sow fear, distrust ahead of German vote, researchers find

Others Also Read